{"disease":{"id":"adme","name":"adme"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07083817","title":"Mass Balance Study of [14C]Xeruborbactam (QPX7728) in Healthy Adult Male Participants","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":8,"lead_sponsor_name":"Qpex Biopharma, Inc.","has_results":false},{"nct_id":"NCT03525405","title":"A Study to Evaluate the Mass Balance of 14C-Napabucasin in Healthy Adult Male Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":8,"lead_sponsor_name":"Sumitomo Pharma America, Inc.","has_results":false},{"nct_id":"NCT05023811","title":"A Study of the ADME of [14C]RIST4721 in Healthy Male Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":6,"lead_sponsor_name":"Aristea Therapeutics, Inc.","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}